Saleh Al-Muqar | Microbiology | Excellence in Research Award

Mr. Saleh Al-Muqar | Bacteriology | Excellence in Research Award

Mr. Saleh Al-Muqar, Albaydha University, Yemen.

🧬 Dr. Saleh Mohammed Saleh Al-Maaqar is a Yemeni researcher and Ph.D. candidate in Microbiological Sciences at King Abdulaziz University, Saudi Arabia. He specializes in infectious diseases, nanotechnology, and antimicrobial resistance. With over 15 peer-reviewed publications, his work includes novel approaches to combat MDR bacteria and develop green nanoparticles. He also serves as a lecturer at Albaydha University, Yemen. His dedication reflects excellence in innovative biomedical research. πŸŒ±πŸ”¬πŸ“š

Profile

Orcid Profile

Google Scholar Profile

πŸŽ“ Early Academic Pursuits

Saleh Mohammed Saleh Al-Maaqar began his academic journey with a strong foundation in Biological Sciences, earning his BSc in 2008 from Thamar University in Yemen. His commitment to knowledge led him to pursue an MSc in Biological Sciences at King Abdulaziz University (KAU), Saudi Arabia, which he completed in 2020. Driven by a passion for microbiological research, he is currently pursuing a Ph.D. in Microbiological Sciences at the same institution, marking a significant milestone in his scholarly growth.

πŸ₯ Professional Endeavors

Saleh began his professional career as a teacher at the Ministry of Education in Yemen (2009–2010). He later transitioned into academia as an Assistant Lecturer at Al-Baydha University (2010–2014). These early roles allowed him to develop a strong pedagogical foundation while nurturing a research-oriented mindset that he would further cultivate during his doctoral journey in Saudi Arabia.

πŸ”¬ Contributions and Research Focus On Microbiology

Mr. Al-Maaqar has a deep research interest in infectious diseases, nanotechnology, and experimental medicine. His work includes food-borne pathogens like E. coli, Shigella, Salmonella, and Klebsiella, as well as multi-drug resistant (MDR) bacteria. Currently, his doctoral research explores the pharmacological properties of plant-based compounds such as Lavandula dentata, Capparis cartilage, and Saussurea costus, especially their effects on meningitis-causing bacteria.

🌍 Impact and Influence

Through his interdisciplinary approach, Mr. Al-Maaqar is contributing to global public health solutions by developing sustainable antimicrobial strategies. His research on nanoparticle synthesis using plant extracts and natural product-based therapeutics has opened promising avenues for addressing antibiotic resistance, a critical healthcare challenge worldwide.

🧠 Research Skills

Mr. Al-Maaqar is proficient in a range of advanced research techniques, including antimicrobial susceptibility testing (DDT, WDT, MIC, MBC, and time-kill curves), isolation and identification of bacteria, natural product extraction, and the use of software tools like SPSS, EndNote, and Mendeley. Additionally, he has a secretarial diploma in computer sciences, further supporting his data analysis and documentation capabilities.

πŸ… Awards and Honors

While specific awards are not listed, Mr. Al-Maaqar’s publication track record and international academic engagement signify high scholarly merit. His acceptance into a Ph.D. program at a top-tier university and collaboration with renowned scientists worldwide underscore his professional recognition and research excellence.

πŸ›οΈ Legacy and Future Contributions

As a rising scholar in microbiology and nanomedicine, Saleh Al-Maaqar is poised to leave a significant legacy through his ongoing research on plant-based antimicrobials and bacteriophage therapy. With the potential to develop eco-friendly therapeutic agents and reduce dependency on synthetic antibiotics, his future contributions are expected to influence both academia and industry. His vision aligns with global efforts toward sustainable healthcare innovations, and he is likely to become a prominent voice in the scientific community.

Publications Top Notes

  • πŸ§ͺ Biosynthesis of Novel Ag-Cu Bimetallic Nanoparticles from Leaf Extract of Salvia officinalis and Their Antibacterial Activity
    πŸ“˜ Journal: Life 13 (3), 653
    πŸ”’ Citations: 37
    πŸ“… Year: 2023

  • 🍯 In vitro antibacterial activity of honey against multidrug-resistant Shigella sonnei
    πŸ“˜ Journal: Complementary Therapies in Clinical Practice 41, 101257
    πŸ”’ Citations: 22
    πŸ“… Year: 2020

  • 🌿 The effect of different aqueous solutions ratios of Ocimum basilicum utilized in AgNPs synthesis on the inhibition of bacterial growth
    πŸ“˜ Journal: Scientific Reports 13 (1), 5866
    πŸ”’ Citations: 16
    πŸ“… Year: 2023

  • βš—οΈ Optimization of biocatalytic steps via response surface methodology…
    πŸ“˜ Journal: Catalysis Letters 153 (9), 2543–2557
    πŸ”’ Citations: 13
    πŸ“… Year: 2023

  • 🌱 Effect of Different Ratios of Mentha spicata Aqueous Solution…
    πŸ“˜ Journal: Journal of Nanomaterials 2023 (1), 3599501
    πŸ”’ Citations: 10
    πŸ“… Year: 2023

  • πŸƒ Sensitivity of multidrug-resistant pathogenic bacteria to ethanolic extract of Ziziphus spina-christi L.
    πŸ“˜ Journal: Bioscience Research 19 (3), 1467–1475
    πŸ”’ Citations: 10
    πŸ“… Year: 2022

  • 🍯 Susceptibility of multidrug-resistant enteric pathogenic diarrheal Bacteria to Saudi Honey
    πŸ“˜ Journal: JKAU: Science 32 (1), 47–64
    πŸ”’ Citations: 9
    πŸ“… Year: 2020

  • 🌸 Phytochemical characterization and multifaceted bioactivity… Clinopodium nepeta
    πŸ“˜ Journal: CyTA – Journal of Food 22 (1), 2348735
    πŸ”’ Citations: 5
    πŸ“… Year: 2024

  • πŸ”¬ Antibacterial and antibiofilm activity of extracts from sponge-associated bacterial endophytes
    πŸ“˜ Journal: Preparative Biochemistry & Biotechnology 53 (9), 1143–1153
    πŸ”’ Citations: 5
    πŸ“… Year: 2023

  • 🍯 SCREENING OF LACTIC ACID BACTERIA FROM SELECTED SAUDI HONEY…
    πŸ“˜ Journal: β€”
    πŸ”’ Citations: 5
    πŸ“… Year: 2023

  • 🌊 Isolation and identification of biofilm bacteria from microfouling… Red Sea
    πŸ“˜ Journal: JKAU: Marine Science 31, 45–54
    πŸ”’ Citations: 5
    πŸ“… Year: 2021

  • 🧫 Development of silver-doped copper oxide and chitosan nanocomposites…
    πŸ“˜ Journal: Zeitschrift fΓΌr Naturforschung C 79 (5–6), 137–148
    πŸ”’ Citations: 4
    πŸ“… Year: 2024

  • 🧲 Iron-Based Nanoparticles Synthesis, Characterization, and Antimicrobial Effectiveness
    πŸ“˜ Journal: Advancements in Life Sciences 11 (2), 525–532
    πŸ”’ Citations: 3
    πŸ“… Year: 2024

  • 🧼 Optimization and Detergent Compatibility of Protease from Aspergillus oryzae…
    πŸ“˜ Journal: ACS Omega 9, 17446βˆ’17457
    πŸ”’ Citations: 3
    πŸ“… Year: 2024

  • 🧫 Bactericidal Activity of Coleus forskohlii Extract Against MDR Acinetobacter baumannii
    πŸ“˜ Journal: Bioscience Biotechnology Research Communications 14 (3), 1265–1271
    πŸ”’ Citations: 2
    πŸ“… Year: 2021

  • πŸ„ Serological investigation of Coxiella burnetii in livestock in Makkah Province
    πŸ“˜ Journal: Veterinary World 17 (4), 842–847
    πŸ”’ Citations: 1
    πŸ“… Year: 2024

  • 🏜️ Screening Desert Soils in Makkah Province for Actinomycetes Producing Antibiotics
    πŸ“˜ Journal: β€”
    πŸ”’ Citations: 1
    πŸ“… Year: 2021

  • 🍯 Evaluation of the antibacterial activity of local honey against bacteria causing diarrhea
    πŸ“˜ Journal: King Abdulaziz University Jeddah
    πŸ”’ Citations: 1
    πŸ“… Year: 2020

 

Robert Cooney | Microbiology | Best Researcher Award

Dr. Robert Cooney | Microbiology | Best Researcher Award

Dr. Robert Cooney, SUNY Upstate Medical University, United States.

πŸ”Ή Robert N. Cooney, MD, FACS, FCCM is a distinguished Professor and Patricia J. Numann Endowed Chair in the Department of Surgery at SUNY Upstate Medical University. With a B.A. in Biochemistry from the University of New Hampshire and an M.D. from UVM College of Medicine, he has held key leadership roles in surgery, trauma, and critical care. Dr. Cooney has contributed significantly to medical education, research, and surgical quality initiatives, securing funding from NIH, DoD, and NSF. πŸš€

Profile

πŸŽ“ Early Academic Pursuits

Dr. Robert N. Cooney embarked on his academic journey at the University of New Hampshire, where he earned a B.A. in Biochemistry with Honors in 1979. His strong foundation in biochemistry paved the way for his enrollment at the UVM College of Medicine, where he obtained his M.D. degree in May 1985, with a Senior Major in Surgery. His commitment to surgical excellence was evident from the outset, as he pursued rigorous clinical training in esteemed institutions.

πŸ’Ό Professional Endeavors

Dr. Cooney has held multiple prestigious positions throughout his career, currently serving as Professor and Patricia J. Numann Endowed Chair, Department of Surgery at SUNY Upstate Medical University. His professional trajectory includes roles such as Chief of General Surgery, Vice-Chair for Research, Co-Director of the Penn State Institute for Diabetes and Obesity, and Chief of Bariatric Surgery. His leadership and administrative skills have contributed to the growth and development of numerous surgical programs.

πŸ”¬ Contributions and Research Focus

Dr. Cooney’s research is deeply rooted in surgical critical care, trauma, and metabolic response to injury. His investigative work has secured funding from top agencies like the National Institutes of Health (NIH), Department of Defense (DoD), and National Science Foundation (NSF). As an active researcher and mentor, he has played a crucial role in advancing the understanding of critical care management, bariatric surgery, and trauma care protocols.

🌍 Impact and Influence

Dr. Cooney has profoundly impacted the field of surgery through his leadership, mentorship, and policy development. Under his guidance, the Surgery Department at SUNY Upstate Medical University has expanded significantly, enhancing its pediatric surgery, trauma, and transplant programs. His dedication to surgical quality is evident in his role as the Surgery Quality Officer and his contributions to NSQIP and the UNYSQI collaborative.

πŸ…Certifications & CredentialsΒ 

Dr. Robert Cooney holds prestigious certifications that emphasize his exceptional expertise in surgery and critical care. He is a Fellow of the American College of Surgeons (1995) and a Fellow of the American College of Critical Care Medicine (1999). His qualifications are enhanced by certifications in Surgery Critical Care through the American Board of Surgery in 1993, 2003, and 2013. Additionally, he is a Diplomate of the National Board of Medical Examiners (1986) and holds various provider certifications, including ATLS and ACLS.

πŸ† Awards and Recognitions

Dr. Cooney’s accomplishments have earned him numerous awards and honors. Notable recognitions include the 2022 SUNY Chancellor’s Award for Excellence in Faculty Service, and the 2017 Patricia J Numann Endowed Chair of Surgery. His contributions to surgical education were honored with the Ballentine Award for Excellence in Surgical Education (2003). He has also been featured in Who’s Who Among America’s Teachers and Educators (2007), and the Best Doctors in America list (2002-2015).

πŸ“š Academic Cites

Dr. Cooney’s scholarly contributions are well-recognized, with numerous citations in peer-reviewed journals and medical publications. His work has been widely referenced in research related to trauma surgery, metabolic response, and critical care. As an educator, he has also contributed to medical textbooks and surgical guidelines, enriching the knowledge base for future surgeons.

πŸ’ͺ Legacy and Future Contributions

As a distinguished surgeon, educator, and researcher, Dr. Cooney continues to shape the future of surgery. His legacy is built on his commitment to education, innovation in research, and enhancement of patient care standards. Looking ahead, he aims to further expand research initiatives, mentor the next generation of surgeons, and drive improvements in surgical quality and trauma care protocols.

Publications Top Notes

1. Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome: results from a randomized, double-blind, placebo-controlled trial
πŸ“– Journal: Jama
πŸ”’ Citations: 1364
πŸ“… Year: 1994

2. Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock
πŸ“– Journal: The Lancet
πŸ”’ Citations: 895
πŸ“… Year: 1998

3. Limits of body mass index to detect obesity and predict body composition
πŸ“– Journal: Nutrition
πŸ”’ Citations: 779
πŸ“… Year: 2001

4. Obesity-related elevations in plasma leucine are associated with alterations in enzymes involved in branched-chain amino acid metabolism
πŸ“– Journal: American Journal of Physiology-Endocrinology and Metabolism
πŸ”’ Citations: 559
πŸ“… Year: 2007

5. Validation of several established equations for resting metabolic rate in obese and nonobese people
πŸ“– Journal: Journal of the American Dietetic Association
πŸ”’ Citations: 421
πŸ“… Year: 2003

6. Analysis of estimation methods for resting metabolic rate in critically ill adults
πŸ“– Journal: Journal of Parenteral and Enteral Nutrition
πŸ”’ Citations: 300
πŸ“… Year: 2009

7. Use of a human patient simulator in the development of resident trauma management skills
πŸ“– Journal: Journal of Trauma and Acute Care Surgery
πŸ”’ Citations: 261
πŸ“… Year: 2001

8. Suppressors of cytokine signaling (SOCS): inhibitors of the JAK/STAT pathway
πŸ“– Journal: Shock
πŸ”’ Citations: 242
πŸ“… Year: 2002

9. Abandon the mouse research ship? Not just yet!
πŸ“– Journal: Shock
πŸ”’ Citations: 182
πŸ“… Year: 2014

10. IL-1 receptor antagonist attenuates sepsis-induced alterations in the IGF system and protein synthesis
πŸ“– Journal: American Journal of Physiology-Endocrinology and Metabolism
πŸ”’ Citations: 182
πŸ“… Year: 1996